Humira® UK Patent Trial Began Monday
By EsqSocial Corporation 23/01/17
Samsung Bioepis, Biogen, and Fujifilm Kyowa Kirin Biologics are seeking to invalidate some of AbbVie’s patents related to Humira® (adalimumab) before the UK High Court of Justice. The patents at issue relate to methods of treatment....
By: Goodwin